Share this article
Share this article
PHOENIX, Feb. 17, 2021 /PRNewswire/ Item 9 Labs Corp. (OTCQX: INLB) ( Item 9 Labs or the Company ), a vertically integrated cannabis operator that produces premium products, today announced that Andrew Bowden, CEO of Item 9 Labs, will present live to an online audience at the Benzinga Cannabis Capital Conference being held February 25-26, 2021. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis sector.
Item 9 Labs Presentation at Benzinga Cannabis Capital Conference
- DATE: Thursday, February 25, 2021
- TIME: 11:30 AM Eastern Time
Bowden will provide an overview of the Company, including its award-winning products, the ongoing operations expansion and other key initiatives, as well as the growth opportunities resulting from the favorable regulatory environment. He also plans to speak in-depth on why franchising is the growth vehicle that will propel the ca
Item 9 Labs Reports Record Revenue for Fiscal Year 2020
- Annual revenue growth of 65% fueled by increases in production and market demand
- Stage is set for 2021 developments across Arizona cannabis product expansion and new distribution through merger with national dispensary franchise
News provided by
Share this article
Share this article
PHOENIX, Jan. 13, 2021 /PRNewswire/ Item 9 Labs Corp. (OTCQX: INLB) ( Item 9 Labs or the Company ), a vertically integrated cannabis operator that produces premium products, today reported the Company s operating and financial results for the fiscal year (FY) ended September 30, 2020.
Key Financial Highlights for FY 2020
Revenue increased 65% to $8.1 million
Gross profit increased 39% to $3.3 million